Skip to Main Content

Advertisement

Skip Nav Destination

Abstract CT100: First-in-human phase 1 trial of pyrimidine anti-metabolite FF-10502-01 in patients with advanced cancer

Cancer Res (2017) 77 (13_Supplement): CT100.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Shinji Mima
  • Chihaya Kakinuma
  • Tamami Higuchi
  • Kazunori Saeki
  • Takayuki Yamada
  • Rena Uematsu
  • Miki Ishino
  • Nobuko Kito
  • Hiroki Nishikawa
  • Hidenobu Kuniyoshi
  • Takuya Matsumoto
  • Hideyasu Fujiwara
  • Linda J. Paradiso
  • Yasuhiro Shimada
  • Hiroyuki Iwamura
Journal of Pharmacology and Experimental Therapeutics (2018) 366 (1): 125.
Close Modal

or Create an Account

Close Modal
Close Modal